Emergent BioSolutions (EBS) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $0.91.
- Emergent BioSolutions' EPS (Weighted Average and Diluted) fell 5582.52% to $0.91 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.31, marking a year-over-year increase of 13250.62%. This contributed to the annual value of -$3.6 for FY2024, which is 7578.3% up from last year.
- Emergent BioSolutions' EPS (Weighted Average and Diluted) amounted to $0.91 in Q3 2025, which was down 5582.52% from -$0.22 recorded in Q2 2025.
- Emergent BioSolutions' 5-year EPS (Weighted Average and Diluted) high stood at $3.29 for Q4 2021, and its period low was -$5.38 during Q2 2024.
- In the last 5 years, Emergent BioSolutions' EPS (Weighted Average and Diluted) had a median value of -$0.59 in 2024 and averaged -$0.9.
- In the last 5 years, Emergent BioSolutions' EPS (Weighted Average and Diluted) surged by 61250.0% in 2021 and then crashed by 1050000.0% in 2022.
- Emergent BioSolutions' EPS (Weighted Average and Diluted) (Quarter) stood at $3.29 in 2021, then crashed by 140.67% to -$1.34 in 2022, then surged by 34.2% to -$0.88 in 2023, then skyrocketed by 32.89% to -$0.59 in 2024, then skyrocketed by 254.09% to $0.91 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.91 in Q3 2025, compared to -$0.22 in Q2 2025 and $1.19 in Q1 2025.